The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK
Citation
Brusselle , G , Price , D , Gruffydd-Jones , K , Miravitlles , M , Keininger , D L , Stewart , R , Baldwin , M & Jones , R C 2015 , ' The inevitable drift to triple therapy in COPD : an analysis of prescribing pathways in the UK ' , International journal of chronic obstructive pulmonary disease , vol. 10 , no. 1 , pp. 2207-2217 . https://doi.org/10.2147/COPD.S91694
Rights
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.